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Abstract
Objective: To evaluate whether Attachment-Based Family Therapy (ABFT) is more
effective than Enhanced Usual Care (EUC) for reducing suicidal ideation and depressive
symptoms in adolescents. Method: Randomized controlled trial of suicidal adolescents between
the ages of 12 and 17, identified in primary care and emergency departments. Of 341 adolescents
screened, 66 (70% African American) entered the study for 3 months of treatment. Assessment
occurred at baseline, six weeks, 12 weeks, and 24 weeks. ABFT consisted of individual and
family meetings, and EUC consisted of a facilitated referral to other providers. All participants
received weekly monitoring and access to a 24-hour crisis phone. Trajectory of change and
clinical recovery were measured for suicidal ideation and depressive symptoms. Results: Using
intent-to-treat, patients in ABFT demonstrated significantly greater rates of change on selfreported suicidal ideation at post-treatment and benefits were maintained at follow-up, with a
strong overall effect size (ES = .97). Between-group differences were similar on clinician ratings.
Significantly more patients in ABFT met criteria for clinical recovery on suicidal ideation posttreatment (87%; 95% CI, 74.6-99.6) than patients in EUC (51.7%; 95% CI, 32.4-54.32). Benefits
were maintained at follow-up (ABFT, 70%; 95% CI, 52.6-87.4; EUC 34.6%; 95% CI, 15.654.2), with a strong effect size (OR = 4.41). Patterns of depressive symptoms over time were
similar, as were results for a subsample of adolescents with diagnosed depression. Conclusions:
ABFT is more efficacious than EUC in reducing suicidal ideation and depressive symptoms in
adolescents. Additional research is warranted to confirm treatment efficacy and test the
proposed mechanism of change.
Keywords: adolescents, suicide, family therapy
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Introduction
Suicide is the third leading cause of death in American adolescents, accounting for 1,371
deaths of youth between the ages of 12 and 18 in 2005.1 In addition, every year nearly one
million adolescents attempt suicide, leading to high emotional costs for families and financial
costs for the health system.2 Unfortunately, no medication and few (less than 10) psychotherapy
studies have focused on suicidal youth.3 Existing studies demonstrate only a slight reduction in
suicide attempts or ideation, and experimental treatments have rarely been superior to treatment
as usual.4-7 Cognitive Behavioral Therapy (CBT)8 and/or medication successfully reduced mild
suicidal ideation in a depressed sample (TADS 12), but not in a more severely depressed and
suicidal population .9 Overall, the efficacy of CBT and other forms of psychotherapy for suicidal
youth has been mixed,3,10 and debate continues over whether medication exacerbates or reduces
suicidal thinking.11 Clearly, research on alternative intervention approaches is warranted.
Family-based treatments for youth suicide are promising for a number of reasons. First,
negative family functioning (e.g., high conflict, low cohesion, poor attachment, ineffective
parenting, etc.) is a strong risk factor for youth suicide and depression.12 Family conflict may
precede 20% of suicide deaths and 50% of non-fatal suicidal acts.13 Second, family conflict is
frequently a negative moderator of treatment outcome.8,9,14 Third, family cohesion, emotional
support, and appropriate supervision are protective factors in preventing suicide and
depression.12
Not surprisingly, several family intervention studies have shown promise for treating
suicidal youth. Harrington et al., found routine care plus family intervention more effective at
reducing suicidal ideation than routine care alone, but only for youth without major depression.15
Huey et al. found Multisystemic Family Therapy more effective than hospitalization for

3

Family Therapy for Suicidal Youth
decreasing suicide attempts but not suicidal ideation, depressive affect, or hopelessness.16 Brent
et al., found CBT and family therapy for depressed adolescents had significant reductions in
suicidal ideation compared to supportive therapy post-treatment, but no difference at follow-up.14
One promising intervention is ABFT, the first manualized family therapy specifically
designed to target family processes associated with depression and suicide. ABFT aims to
improve the family’s capacity for problem solving, affect regulation, and organization. This
strengthens family cohesion, which can buffer against suicidal thinking, depression, and risk
behaviors.12 In a study of ABFT for depressed adolescents, the treatment was found to
significantly reduce suicidal ideation.17
This study tested the efficacy of ABFT for reducing suicidal ideation in adolescents. This
study was designed and powered specifically to examine reductions in suicidal ideation. While
many adolescents may think about suicide sometimes, severe and persistent ideation is a serious
risk factor for suicidal behavior.2,3,18 In addition, these youth present a worrisome challenge for
parents, teachers, mental health and medical professionals, all of whom fear that ideation may
lead to attempts. Unfortunately, ideators are often excluded from clinical trials because of the
safety risks19 and no prevention or treatment studies target youth with severe ideation. Moreover,
few studies have included a large sample of inner city, minority youth, a group whose risk for
suicide has risen dramatically in the last decade.20 With funding from the Centers for Disease
Control and Prevention, we aimed to test whether ABFT reduced suicidal ideation and
depressive symptoms more than Enhanced Usual Care (EUC). Because treatment retention has
been a challenge in treating suicidal youth,21,22 we also aimed to see if ABFT had better retention
than treatment in the community.
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Method
Procedures
The research occurred in the Department of Psychiatry at the Children’s Hospital of
Philadelphia (CHOP). Patients were recruited mainly from CHOP’s primary care offices and
emergency room. During routine clinical interviews, patients identified as having suicidal
thoughts were referred to the clinic social worker for an assessment. Adolescents who endorsed
scores above 31 on the Suicidal Ideation Questionnaire (SIQ-JR)23 and above 20 on the Beck
Depression Inventory (BDI-II)24 (i.e., moderate depression) were referred to our study. On a
second screening, generally two days later (M = 2.21 days, SD = 1.34), if both suicide and
depression scores remained above the cut-offs, patients were eligible for the study. For this highrisk group, a longer waiting period was deemed unethical. Patients had to be between 12 and 17
years old with a parent or guardian willing to participate.
Adolescents were not eligible if they 1) needed psychiatric hospitalization, 2) were
recently discharged from a psychiatric hospital, 3) had current psychosis, or 4) had mental
retardation or history of borderline intellectual functioning. Patients could remain on
antidepressant medication if they had started it at least 12 weeks prior to randomization.
Eligible adolescents and parents signed a written, informed consent and were then
randomized to either ABFT or EUC. Assessments were conducted at baseline, six weeks, 12
weeks (post-treatment), and 24 weeks (follow-up, 12 weeks after treatment). All assessment staff
had a B.A. in psychology and were trained, certified and supervised by the project coordinator.
The study was approved by the IRB at CHOP.
We used an adaptive or "urn" randomization procedure, maintained by the statistician,
with four stratification variables: age, gender, past suicide attempt, and family conflict. The
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project coordinator was blind to the randomization sequence until the baseline assessment was
complete. Given limited grant resources and clinical severity of the patients, blinding assessors
to treatment assignment was not feasible.
Seven Ph.D. or MSW-level therapists provided ABFT (4 female, 3 male). Six were
Caucasian and one was Asian-American. Each were trained, certified, and supervised by the first
and fourth authors. Fidelity to treatment was monitored through weekly case discussion,
videotape review, and live supervision.
Treatments
Attachment-Based Family Therapy (ABFT). ABFT17,25 emerges from interpersonal
theories that suggest depression and suicide can be precipitated, exacerbated, or buffered against
by the quality of family relationships.26 Therefore, ABFT focuses on strengthening parentadolescent attachment bonds to create a protective and secure base for adolescent development.
Therapy begins with a discussion of what prohibits the adolescent from turning to his or her
parent(s) for help when contemplating suicide. Family barriers ranged from a) stress due to the
adolescent’s depression, b) a history of negative interactions and communication, c) abuse,
neglect, abandonment and or d) parental psychopathology. Even well-functioning families
needed help effectively managing these suicidal crises.
Although ABFT therapists implement behavior focused and psychoeducational
interventions, the model is primarily a process oriented, emotion focused treatment, guided by a
semi-structured treatment protocol. Treatment is conceptualized as five specific tasks, each with
a distinct process and goal. Treatment begins with the Relational Reframe Task, conducted with
relevant family members, and aims to strengthen and or repair family relationships (as opposed
to behavior management) as the primary initial treatment goal. Then the Adolescent Alliance
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Task, with the adolescent alone, identifies core family conflicts linked to depression and prepares
the adolescent to discuss these with his or her parents (1 to 2 sessions).
Next, the Parent Alliance Task with the parents alone aims to amplify parental love and
empathy, and to teach emotionally focused parenting skills that will increase affective
attunement (1 to 2 sessions). These sessions culminate in the Reattachment Task, where families
come back together to discuss identified problems and practice new communication, problem
solving, and affect regulation skills (3 to 4 sessions). As attachment relationships strengthen,
therapists focus on the Competency Task. This task promotes adolescent autonomy (e.g.,
improving school functioning, increasing pleasant activities, etc.) while maintaining family
connection. This ideal progression of tasks is modified as needed.
Enhanced Usual Care (EUC). EUC was a facilitated referral process with ongoing
clinical monitoring. We found providers, set up initial appointments, and encouraged attendance.
It was the treating therapist’s responsibility to engage and retain the adolescent in treatment.
Safety Monitoring. We monitored patient’s clinical status weekly using the SIQ-JR and
BDI-II, administered either face-to-face (ABFT) or over the phone (EUC). Information regarding
service utilization was gathered weekly. In addition, project staff were on call all the time in case
of emergency.
Outcome Measures
All outcome assessments were conducted face to face for all patients. The study had two
declared primary outcomes: suicidal ideation and depressive symptoms. The self-report SIQ-JR23
and assessor-administered Scale for Suicidal Ideation (SSI)27 were used to assess trajectory of
change in suicidal ideation over time (total scores). For clinical recovery, we used the SIQ-JR
<13 (based on a non clinical inner city, minority sample28 and SSI = 0). The SSI was
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dichotomized because the data was not normally distributed, and to evaluate the treatment based
on the absence of ideation.29 The self-report BDI-II was used to assess trajectory of change (total
score) in depressive symptoms and clinical response (BDI-II < 9).14,24
Treatment retention was a secondary outcome, measured as number of sessions attended.
For descriptive purposes and subgroup analyses, psychiatric diagnosis was determined using the
clinician-administered, computerized Diagnostic Interview Schedule for Children (DISC).30
Data Analysis
Statistical Methods
Tests of baseline differences in demographic and clinical characteristics were conducted
using independent samples t-tests for continuous variables and Chi-square or Fisher exact tests of
independence for categorical variables. Implementation of various Box-Cox transformations
indicated a square-root transformation would correct the deviations in normality for the SIQ-JR
and the BDI-II (both were negatively skewed). No substantial improvement in near normality
was achieved for the SSI, so it was dichotomized.29
The outcome analyses examined change across all four assessments. Hierarchical linear
modeling (HLM) was used to investigate treatment differences using the intent-to-treat sample.31
For the SIQ-JR and the SSI, the main efficacy analysis was determined to be piecewise,
modeling the rate of change from baseline to 12 weeks (end of active treatment), and then again
at 24 weeks (follow-up). For the BDI-II, the piecewise model ran first from baseline to 6 weeks
(mid-treatment) and then to 24 weeks. For the binary outcomes, including clinical response, we
implemented a hierarchical generalized linear model (HGLM), which accommodates the binary
nature of the data, as well as the clustering within each subject. Effect size was measured using
Cohen’s d for the continuous measures and odds ratios (OR) for the binary measures. The OR
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corresponded to, on average, the number of times an event was more likely to occur for ABFT
compared to EUC at each assessment.
Nonparametric Wilcoxon Rank sum tests were used to compare number of sessions
attended. Chi-square analyses were used to assess treatment retention at each assessment. The
pattern-mixture model approach was used to assess whether missing data had a substantive
influence on results. All analyses were conducted using SPSS Version 15 and SAS Version
9.1.3.
Statistical Power
We originally estimated a required sample size of 120 patients for the longitudinal
analysis of SIQ-JR. Given the time needed for creating a referral infrastructure with primary care
and the short recruitment window (26 months), we did not achieve the targeted goals. The
obtained sample sizes of 35 (ABFT) and 31 (EUC), with a 14.4% missing data rate at the 24
week follow-up assessment, and an approximate intra-subject correlation of .40 (estimated value
of 0.34 for the SIQ-JR scale), indicated the study power of 74.5%. Such power would yield a
statistically significant result for an effect size of 0.60, power of 81.0% for an effect size of 0.65,
and power of 86.4% for an effect size of 0.70.
Results
Enrollment Statistics
Between March 2005 and May 2007, 341 adolescents were referred for the first screening
(Figure 1). Of the 248 who were excluded, 188 did not meet study criteria, 36 became
unreachable prior to the second screening, 14 refused study participation, six were hospitalized,
and four were excluded for other reasons. Of the 93 who attended the second screening, 11 no
longer met study criteria, eight were unreachable prior to consent, and five refused study
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participation. Of the 69 who qualified based on the second screening, three reported psychotic
features during intake and were excluded. Of the final sample, 50 participants (75%) were
referred from primary care, and 16 (25%) were referred from emergency departments.
Demographic, Clinical, and EUC Characteristics
There were no differences on any demographic or clinical variables between the two
treatment conditions (Table 1). The mean age was 15.1 years (SD = 1.5), 49 (74%) were African
American, and 55 (83%) were female. Of the parents, 27 (41%) had an income under $30,000,
17 (26%) were married and 46 (70%) had no more than a high school diploma. Thirty-one (47%)
adolescents met criteria for a depressive disorder, 44 (67%) met criteria for any anxiety disorder,
and 38 (57%) met criteria for an externalizing disorder (i.e., ADHD, oppositional, or conduct
disorder). Forty-one (62%) participants reported having made a past suicide attempt, and nearly
three quarters of those patients (30 of the 41 attempters) reported making multiple attempts.
Twenty (30%) participants reported a history of suicide attempts in their families. Upon study
entry, six patients were stable (more than 12 weeks) on antidepressant medication, three in each
treatment condition.
Of the patients in EUC, seven (23%) were referred to private practice, and 24 (77%) were
referred to community mental health centers. Sixteen (52%) received individual therapy, six
(19%) received group therapy, two (6%) received family therapy, one (3%) received case
management, and six (19%) did not attend treatment. There were no differences in the
completion rates of assessments between the two treatment groups at any of the time points.
Implementation of the pattern-mixture approach indicated group comparisons were not biased
due to completion status.
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Trajectory of Change: Suicidal Ideation
On self-reported suicidal ideation (i.e., SIQ-JR), ABFT demonstrated a significantly
greater rate of improvement during the treatment period (12 weeks) than EUC (F (1, 64) = 12.60,
P = 0.001) (Figure 2; Table 2). No significant difference in rates of change was observed
between treatments during the follow-up phase (F(1, 64) = 0.01, P < 0.91). During the treatment
phase, the amount of change on the square-root of the SIQ-JR scale was -5.32 (se = 0.38) for
ABFT and -3.35 (se = 0.40) for EUC. This corresponded to a significant difference of -1.97 (se =
0.55) with a large effect size (d = .95) in favor of ABFT (t(64) = 3.55, P = 0.0007). The total
change from baseline to follow-up on the square-root of the SIQ-JR for ABFT was -4.37 (se =
0.40) and for EUC -2.34 (se = 0.43). This corresponded to a significant difference of 2.03 (se =
0.59) with a large effect size (d = 0.97), in favor of ABFT (t(64) = -3.45, P = 0.001). Therefore,
despite the slight increase of suicidal ideation for both groups during the follow-up phase, the
large effect in favor of ABFT was maintained.
Regarding the trajectory of change of clinician-rated suicidality (SSI), ABFT
demonstrated a significantly greater rate of change on the log-odds scale than EUC during the
treatment phase (F(1,64)=6.32, P = 0.014). During the follow-up phase, there was no significant
difference in rate of change between the two groups (F(1,64 ) = 0.20, P = 0.65). During the
treatment phase, the amount of change on the log-odds SSI for ABFT was 2.51 (se = 0.51) and
for EUC was 0.77 (se = 0.47). This corresponded to a significant difference of 1.74 (se = 0.69)
with a medium to larger effect size (d = 0.62) in favor of ABFT (t(64) = 2.51, P = 0.014). The
total change from baseline to follow-up on the log-odds SSI scale for ABFT was 3.21 (se = 0.61)
and for EUC 1.14 (se = 0.53). This corresponded to a significant difference of 2.07 (se = 0.80)
with a medium to large effect size (d = 0.64) in favor of ABFT (t(64) = 2.58, P = 0.012).
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Therefore, while both groups improved after 12 weeks, ABFT continued to have a slightly higher
rate of improvement, with a medium to large effect.
Clinical Recovery: Suicidal Ideation
For clinically meaningful change on the self-reported SIQ-JR (Table 3), ABFT had a
significant effect at all time points and large effect sizes represented by the odds ratios. At six
weeks, 69.7% of ABFT participants and 40.7% of EUC participants reported suicidal ideation in
the normative range (OR = 3.35, 95% CI: 1.15-9.73; χ2(1) =5.07, P = 0.02). At 12 weeks, 87.1%
of ABFT participants and 51.7% of EUC participants reported ideation in the normative range
(OR = 6.30, 95% CI: 1.76-22.61, χ2(1) = 8.93, P = 0.003). At 24 weeks, 70.0% of ABFT
participants and 34.6% of EUC participants reported ideation in the normative range (OR = 4.41,
95% CI: 1.43-13.56; χ2(1) = 7.01, P = 0.008).
Clinical response on clinician-rated SSI demonstrated similar patterns as the SIQ-JR. At
six weeks, 40.7% of ABFT participants and 33.3% of EUC participants reported no suicidal
ideation in the past week (OR = 1.38, 95% CI: 0.44-4.32; χ2(1) = 0.30, P = 0.59). At 12 weeks,
69.2% of the ABFT participants and 34.6% of the EUC participants reported no suicidal ideation
in the past week (OR = 4.25, 95% CI: 1.33-13.56; χ2(1) = 6.24, P = 0.01). At 24 weeks, 82.1%
of the ABFT participants and 46.2% of the EUC participants reported no suicidal ideation in the
past week (OR = 5.37, 95% CI: 1.56-18.49; χ2(1) = 7.66, P = 0.006). Over the six months of the
study, 11 patients made low lethality suicide attempts (ABFT= 4; EUC =7). These numbers are
too small for statistical analysis.
Depressive Symptoms
Trajectory of change on self-reported depressive symptoms (BDI-II) showed a marginally
significant differential rate of change during the first six weeks of treatment between the two
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groups (F (1, 64) = 3.00, P = 0.09). From mid-treatment to follow-up, there was no significant
difference in rate of change between the two groups (F(1, 64) = 0.33, P = 0.57). During the first
six weeks, ABFT demonstrated an average reduction of 2.16 (se = 0.24) while EUC had an
average reduction of 1.55 (se = 0.26) on the square root BDI-II. This corresponded to a near
significant difference of 0.62 (se = 0.353) with a small to medium effect size (d = 0.37; t(64) =
1.75, P = 0.08). For the total change from baseline to follow-up there was a non-significant
difference of 0.36 (se = 0.51) with an effect size (d = 0.22) in favor of ABFT (t(64) = -0.72, P =
0.48).
For clinically meaningful change in depressive symptoms (i.e., BDI-II < 9), we found
marginally significant effects and large effect sizes represented at all time points. At midtreatment, 34.4% of ABFT participants and 11.1% of EUC participants reported depression
scores in the non-clinical range (OR = 4.19; 95% CI: 1.03-17.07; χ2(1) = 4.38 P = 0.04). At posttreatment, 54.8% of ABFT participants and 31.0% of EUC participants reported non-clinical
depression scores (OR = 2.70, 95% CI: 0.94-7.71; χ2(1) = 3.46, P = 0.06). At follow-up, 58.1%
of ABFT participants and 38.5% of EUC participants reported non-clinical depression scores
(OR = 2.21, 95% CI: 0.76-6.42; χ2(1) = 2.17, P = 0.14).
Treatment Retention
ABFT patients attended a significantly greater number of sessions (M = 9.71, SD = 5.26)
than EUC patients (M = 2.87, SD = 3.3; Z = -4.74, P < .001). To determine if treatment rather
than the number of sessions impacted the SIQ-JR scores, we explored the trajectory of change
for the subsample of patients who received no more than six sessions in either treatment (ABFT
= 9; EUC = 27). Similar to the findings in the full sample, analysis of the subsample
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demonstrated that ABFT cases showed a marginally greater rate of change during the active
treatment period compared to EUC (F(1, 34) = 2.84, P = 0.10).
Subsample of Adolescents Diagnosed with Depression
To facilitate comparison with other treatment studies, we looked at rates of change on
SIQ-JR for those patients who met criteria for clinical depression during the past year (n = 35,
53.0%; EUC = 19, 61.3%; ABFT = 16; 45.7%; χ2(1) = 1.60, P = 0.21). Similar to findings from
the full data set, ABFT demonstrated a significantly greater rate of change than EUC for these
depressed participants during the treatment phase (F (1, 33) = 6.16, P = 0.02). During the followup phase, there was no significant difference in rate of change between the two groups (F(1, 33)
= 0.10, P = 0.75). The total change, from baseline to follow-up was -4.35 (se = 0.66) for ABFT
and -2.19 (se = 0.62) for EUC on the square-root SIQ-JR. This corresponded to a significant
difference of 2.16 (se = 0.91) with an effect size (d = 1.00) in favor of ABFT (t(33) = -2.39, P =
0.02). Therefore, the large effect on suicidal ideation in favor of ABFT for clinically depressed
subjects is similar to the effect found for the full sample.
Discussion
The findings from this study are promising. Compared to usual care in the community,
youth treated with ABFT demonstrated significantly greater and more rapid reductions in
suicidal ideation during the treatment. These differences persisted at follow-up with an overall
large effect size. These findings are strengthened by the consistency across self-report and
clinician ratings, and that findings were similar even if patients met criteria for a depressive
diagnosis. ABFT was also associated with greater rates of clinical recovery. For this, we used the
stringent criteria of scores similar to a non-clinical sample, below 13, rather than the SIQ-JR
clinical cut off of 31. On both the SIQ-JR and the SSI, patients in ABFT at post-treatment and
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follow-up, were at least 4 times more likely to show scores in recovery than patients in EUC.
This is one of the few studies to demonstrate that a research treatment was more effective than
treatment as usual for reducing suicidal ideation in adolescents.3
ABFT also demonstrated nearly significant reductions in depressive symptoms by midtreatment compared to EUC, with no difference at post-treatment and follow-up. Effect sizes,
however, at all time points were very strong for ABFT, suggesting that a larger sample size may
have produced statistical significance. In addition, long term differences between treatments for
depression are uncommon,8,14 possibly due to the episodic nature of the disorder. Still, ABFT
provided more rapid relief from depressive symptoms than community care, an important
advantage when youth are at risk for suicide. These findings were supported by the measures of
clinical recovery for depression. Compared to EUC, patients in ABFT were 3 times more likely
to report BDI–II total scores in the non-clinical range at mid-treatment and 2.3 times more likely
at follow-up.
The data on retention was particularly important. ABFT retained adolescents in treatment
longer than usual care, even with the additional support and monitoring offered in EUC. These
findings are meaningful given the difficulties of engaging suicidal youth in outpatient treatment.
While better retention in research based therapy than in community therapy is not surprising, our
retention rates were as good as or better than most clinical trials with suicidal, low income,
minority youth.3, 7,21,22 This may be a factor of the highly structured parent engagement
strategies of ABFT, but more research is needed to test that hypothesis.
Unfortunately, the low EUC retention rate also raises questions about the internal validity
of the study. In other words, what is really causing the change? Differential outcomes may be a
function of the treatment dose and not treatment type? Perhaps an equal dose of community care
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would have achieved a similar outcome as ABFT. Alternatively, maybe outcome and retention
effects were due to therapist differences. This study compared trained, research therapists
receiving close supervision (ABFT) to a range of providers, with varied training backgrounds,
working in a range of treatment settings. These two confounds (i.e., dose and therapist
differences) plague most studies using TAU as a comparison group.32
Despite these limitations, many reasons support enthusiasm for the validity of the results.
First, when comparing all patients that received a low dose of either treatment, patients in ABFT
continued to show better outcomes. Second, if we compare post-treatment scores on the SIQ-JR
across studies, where most samples start above a score of 31, ABFT (M=8) consistently does as
well or better than other experimental treatments: 26 for Peer Nominated Support,5 24.5 for skillbased treatment,7 11.8 for CBT plus fluoxetine, 14.4 for fluoxetine alone, 11.4 for CBT alone
and 15 for placebo.8 While these points are encouraging, conclusive claims about the efficacy of
ABFT for the treatment of suicidal youth will depend on a future study that can address the
design issues outlined above.
Other limitations should be considered. First, assessors were not blind to treatment
assignment. Although not uncommon in studies of high-risk participants,29, 33 the consistency in
findings across self-report and interviewer measures, and across multiple clinical domains, lends
some confidence that assessor bias did not impact the results. Second, three-fourths of the sample
was African American, and nearly half lived below the poverty level. Thus, our findings may not
generalize to more affluent or culturally heterogeneous samples. Therefore, research on ABFT
with more diverse populations is needed. Third, there is not data at this point to indicate when
this treatment might be contraindicted (e.g., family conflict is too high or absent). Certainly, no
treatment is perfect for all patients, though attempting to help any family through a suicidal crisis
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seems clinically appropriate. Fourth, the relatively short follow-up (6 months postrandomization) limits our understanding of long-term treatment benefits. Longer follow-up
would better reflect treatment benefits. Finally, just to be clear, based on this study, we cannot
claim that ABFT prevents suicidal behavior, only that it reduces suicidal ideation.
An important goal of the National Strategy for Suicide Prevention is the development,
testing, and dissemination of effective treatments for youth suicide.2 Family based interventions
have shown efficacy in treating these youth, and ABFT in particular seems a promising treatment
for reducing suicidal ideation and depressive symptoms. However, more empirical evidence on
the efficacy and mechanisms of change for ABFT is warranted before conclusive claims can be
made.
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Table 1. Patient Characteristics
EUC
(n = 31)

ABFT
(n = 35)

P value

Age, mean (SD), y

15.29 (1.83)

15.11 (1.41)

.66

AA race, No. (%)

24 (77.4)

25 (71.4)

.78

Female sex, No. (%)

23 (74.2)

32 (91.4)

.10

Income, less than $30,000 yearly incomea, No. (%)

13 (44.8)

14 (43.8)

1.00

Parent is high-school graduate, No. (%)

21 (84.0)

26 (78.8)

.74

Single-parent household, No. (%)

22 (73.33)

25 (73.53)

.98

Social Services involvement, No. (%)

13 (43.3)

12 (34.3)

.61

Major depressive episode

13 (41.9)

13 (37.1)

.80

Dysthymia

2 (6.5)

3 (8.6)

1.00

Any anxiety

23 (74.2)

21 (60.0)

.30

Externalizing disorder (ADHD, ODD, CD)

15 (48%)

23 (65%)

.16

Adolescent attempted suicide in the past

19 (61.3)

22 (62.9)

1.00

Multiple attemptsc

12 (63.2)

18 (81.8)

.29

Past psychiatric hospitalization

7 (24.1)

7 (20.0)

.77

Taking antidepressant medicine

3 (10.3)

3 (8.6)

1.00

Family history of suicide attempt

10 (34.3)

10 (30.3)

.79

Demographic Characteristics

Current Psychiatric Diagnoses, No. (%)

Clinical History, No. (%)

a

- Income: For the entire sample 27 (44.3%) had income under $30,000; 25 (41%) had income $30,000 - $70,000.

c

- Of those with history of attempt

d

- None were deaths of parents
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Table 2. Rates of Change Estimates

MEASURE

ABFT

PHASE 1
EUC

ABFT

PHASE 2
EUC

estimate (se)

estimate (se)

estimate (se)

estimate (se)

SIQ-JR a

-1.77 (0.13)

-1.12 (0.13)

0.16 (0.06)

0.17 (0.07)

SSI a

0.84 (0.17)

0.26 (0.16)

0.12 (0.09)

0.06 (0.08)

BDI b

-1.39 (0.18)

-0.94 (0.19)

-0.05 (0.05)

0.09 (0.05)

SIQ-JR c

-1.72 (0.21)

-1.08 (0.19)

0.14 (0.09)

0.17 (0.09)

a

– PHASE 1 = change during active treatment; PHASE 2 = change during follow-up.

b

– PHASE 1 = change during the first six weeks of treatment; PHASE 2 = change from 6 weeks to follow-up.

c

– Only depressed participants. PHASES defined as in a.

24

Family Therapy for Suicidal Youth
Table 3. Clinical Response by Treatment
Clinical Response Rate % (CI)
ABFT (n=35)
EUC (n=31)

Odds Ratio

P value

SIQ-JR (<13)
6 week

69.7=23/33 (53.1-86.2)

40.7=11/27(20.9-60.5)

3.35

0.02

12 week

87.1=27/31 (74.6-99.6)

51.7=15/29 (32.4-71.1)

6.30

0.003

24 week

70.0=21/30 (52.6-87.4)

34.6=9/26 (15.0-54.2)

4.41

0.008

6 week

40.7=11/27 (20.9-60.5)

33.3=8/24 (13.0-53.7)

1.38

0.59

12 week

69.2=18/26(50.2– 88.2)

34.6=9/26 (15.0-54.2)

4.25

0.013

24 week

82.1=23/28 (67.0-97.3)

46.2=12/26(25.6– 66.7)

5.37

0.006

6 week

34.4=11/32 (17.0-51.8)

11.1=3/27 (1.6-23.8)

4.19

0.04

12 week

54.8=17/31 (36.3-73.4)

31.0=9/29 (13.1-48.9)

2.70

0.06

24 week

58.1=18/31 (39.7-76.8)

38.5=10/26 (18.4-58.5)

2.21

0.14

SSI (0 vs. 1)

BDI-II (≤ 9)

25

Family Therapy for Suicidal Youth
Table 4. Means and Confidence Intervals
Measure
SIQ

SSI

BDI

Assessment
Baseline

ABFT (n=35)
52.1 (47.5-56.7)

EUC (n=31)
49.9 (44.9-54.9)

6 week

15.0 (7.5-22.5)

22.2 (14.9-29.5)

12 week

5.2 (1.6-8.8)

16.2 (10.1-22.2)

24 week

10.4 (5.6-15.2)

23.0 (15.6-30.4)

Baseline

14.2 (2.1-26.5)

19.4 (4.6-34.1)

6 week

40.7 (20.9-60.5)

33.3 (13.0-53.7)

12 week

69.2 (50.2 – 88.2)

34.6 (15.0-54.2)

24 week

82.1 (67.0-97.3)

46.2 (25.6 – 66.7)

Baseline

33.0 (29.8-36.2)

33.0 (29.7-36.2)

6 week

16.6 (11.5-21.8)

24.5 (18.9-30.1)

12 week

12.6 (8.0-17.2)

18.5 (12.9-24.0)

24 week

12.4 (7.8-16.9)

16.2 (10.4-21.9)
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Figure 1. Study Participants from Initial Screening Through Analysis
341 Adolescents received initial screening
248 Excluded
188 Did not meet study criteriaa
36 Unable to contact
14 Refused consent
6 Hospitalized
4 Other
93 Adolescents received second screening
24 Excluded
11 Did not meet study criteriab
8 Unable to contact
5 Refused consent
69 Underwent baseline assessment
3 Excluded due to psychosis
66 Randomized

35 Attachment Based Family Therapy

31 Enhanced Usual Care

32 Completed > 1 session

21 Completed > 1 session

24 Completed > 6 therapy sessions

6 Completed > 6 therapy sessions

22 Completed > 10 therapy sessions

2 Completed > 10 therapy sessions

33 Completed 6-week assessment

27 Completed 6-week assessment

31 Completed 12-week assessment

29 Completed 12-week assessment

31 Completed 24-week assessment

26 Completed 24-week assessment

35 Included in intent-to-treat analyses

31 Included in intent-to-treat analyses
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Figure 2: SIQ-JR. profile over time (square-root transformed)
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